Cryopreserved ampule of negatively selected Human Peripheral Blood CD14+ Monocytes, containing ≥ 50 million cells
Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing 10 million cells
Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing ≥ 25 million cells
Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing ≥ 1 million cells
Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing ≥ 5 million cells
Antibiotic formulation for prevention of bacteria, fungi and mycoplasma contaminations in cell line cultures.
Cryopreserved ampule of Human CD34+ Progenitor Cells from Mobilized Peripheral Blood using positive immunomagnetic selection containing ≥ 1 million cells
-
TechSheet – Grace’s Insect MediumHot to use Grace's Insect medium
-
Formulation - Grace's Insect MediumComposition of Grace's Insect Medium (04-457)
-
Formulation - Grace's Insect Medium, (04-649)Composition of Grace's Insect Medium (04-649)
-
PyroTec™ PRO Hardware User's ManualThe manual describes the PyroTec™ PRO Robotic System and provides all of the information required for the safe operation and maintenance of the instrument.
-
CellBio Services – Custom Solutions to Meet Your Unique Research NeedsBrochure showcasing Lonza's CellBio Services capabilities including cell isolations and expansions, research grade media production, transfection services, and cell characterization.
-
Reducing Risk, Enhancing Flexibility: Lonza's Approach to Custom Media Manufacturing PresentationCustomer facing presentation on 3PIP
-
Reducing Risk, Enhancing Flexibility: Lonza's Approach to Custom Media Manufacturing PresentationCustomer facing presentation on 3PIP
-
CD34+ Cells for Cell and Gene Therapy Process DevelopmentIn this interview Dr. Manon Destalminil, Bioprocessing Project Leader at CellProthera, discusses the advantages of using research-grade CD34+ cells for cell and gene therapy process development. Please register to read.
-
Why Should I Upgrade to WinKQCL 6 Software?WinKQCL 6 Software expands the core capabilities including ease of use, security and data integrity, and data analysis.
-
WinKQCL™ 5 Software – Discover the Fast Track to Endotoxin AnalysisWebinar about the WinKQCL™ 5 Endotoxin Detection and Analysis Software and how it can help you to analyze, report and trend your data.